Filter
1191
Filtered Results: 1191
Text search:
in
vitro
Featured
Recommendations
137
New Publications
217
Language
Document type
No document type
478
Guidelines
342
Studies & Reports
182
Manuals
85
Fact sheets
47
Strategic & Response Plan
33
Training Material
12
Situation Updates
6
Resource Platforms
4
Brochures
1
Infographics
1
Countries / Regions
Brazil
40
Latin America and the Carribbean
39
Russia
36
India
32
Global
26
Colombia
25
Germany
25
South Africa
21
Paraguay
20
Argentina
17
Africa
15
Western and Central Europe
15
Mozambique
14
Venezuela
14
Bolivia
12
Angola
12
Sierra Leone
11
Peru
11
Ethiopia
10
Kenya
9
Middle East and North Africa
9
Ukraine
8
Rwanda
8
Cameroon
8
Burkina Faso
8
Uganda
8
Eastern Europe
8
Zambia
8
Myanmar / Burma
8
Philippines
7
Spain
7
Indonesia
7
Liberia
7
El Salvador
6
Syria
6
Nigeria
6
Tanzania
6
Eastern Europe and Central Asia
6
Namibia
6
Yemen
6
Chile
5
Guinea
5
West and Central Africa
5
South–East Asia Region
5
Ecuador
5
Senegal
4
Malawi
4
Italy
4
Haiti
4
Guinea-Bissau
4
France
4
Bangladesh
4
Nepal
3
Lesotho
3
Benin
3
Congo-Brazzaville
3
Niger
3
Congo, Democratic Republic of
3
East and Southern Africa
3
Mali
3
Eswatini/ Swaziland
3
Tajikistan
2
Ghana
2
Kazakhstan
2
Asia
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Sudan
2
Honduras
2
Chad
2
South Sudan
2
Madagascar
2
North Macedonia
1
Thailand
1
Mexico
1
Serbia
1
Turkey
1
Gambia
1
Togo
1
Albania
1
Canada
1
Laos
1
Kyrgyzstan
1
Uzbekistan
1
Afghanistan
1
Burundi
1
Zimbabwe
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Armenia
1
USA
1
Dominican Republic
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
North America
1
Belgium
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Lebanon
1
Papua New Guinea
1
Nicaragua
1
Djibouti
1
Egypt
1
Palestine
1
Georgia
1
Libya
1
Iraq
1
Somalia
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
399
Clinical Guidelines
177
Pharmacy & Technologies
57
Women & Child Health
36
Public Health
35
Key Resources
25
Capacity Building
3
Toolboxes
COVID-19
271
TB
126
HIV
114
AMR
58
NTDs
52
Ebola
47
Rapid Response
43
Pharmacy
37
Zika
31
Planetary Health
27
Caregiver
19
Mental Health
18
Refugee
18
Global Health Education
11
NCDs
6
Conflict
6
Polio
6
Specific Hazards
5
Natural Hazards
5
Cholera
5
Health Financing Toolbox
5
Disability
3
Social Ethics
1
SARS-CoV-2 infections among children and adolescents cause less severe illness and fewer deaths compared to adults. While a less severe course of infection is a positive outcome, there are concerns that mild symptoms may have led to less testing, resulting in fewer identified cases of COVID-19 in ch...
The ongoing COVID-19 pandemic has shown that public financial management (PFM) should be an integral part of the response. Effectiveness in financing the health response depends not only on the level of funding but also on the way public funds are allocated and spent, this is determined by the PFM r...
The objective of the 2022 Compendium is to compile and highlight emerging innovative health technologies for low-resource settings. It presents a snapshot of technologies that are solutions to an unmet medical/health technology need or are likely to improve health outcomes and the quality of life. H...
Antimicrobial resistance (AMR) has emerged as a major public health problem all over the world. Infections caused by resistant microbes fail to respond to treatment, resulting in prolonged illness and greater risk of death. This document focuses on the mechanism to develop a practically applicable h...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This manual describes some of the strategic, managerial, financial, technical and scientific aspects to be considered in establishing a national EQA programme for clinical laboratories and other testing services at all health care levels
TNew data from the World Health Organization reveal that the COVID-19 pandemic has disrupted malaria services, leading to a marked increase in cases and deaths.
According to WHO’s latest World malaria report, there were an estimated 241 million malaria cases and 627 000 malaria deaths worldwide i...
This resource consists of technical guidelines for District Medical Officers, counselors and laboratory technicians for second-line antiretroviral therapy drugs, operational guidelines for pilot roll-out in two centres and laboratory guidelines for viral-load testing and standard operating procedure...
The intent of these guidelines is to develop a holistic, coordinated, proactive and technology driven strategy for management of biological disasters through a culture of prevention, mitigation and preparedness to generate a prompt and effective response in the event of an emergency. Th...
Replacement of Annex 2 of WHO Technical Report Series, No. 964...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell...
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
This compendium collates current tools and resources on quality improvement developed by the WHO Service Delivery and Safety Department and provides examples of how the tools and resources have been applied in country settings. The target audience for this document are ministries of health, facility...
The Ministry of Health together with its partners realizes that efficient and effective
delivery of clinical care is highly dependent on the availability of appropriately
upgraded environment, which is in well facilitated space. Such facilities and utilities
should always be properly designed, bu...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
